๐ Our educational video series on clinical trials continues today with ๐ง๐ฎ๐ฐ๐๐ถ๐ฐ๐ ๐ณ๐ผ๐ฟ ๐๐น๐ผ๐ฏ๐ฎ๐น ๐ฃ๐ถ๐๐ผ๐๐ฎ๐น ๐ฆ๐๐๐ฑ๐ถ๐ฒ๐.
Senior Project Manager Guido Rieger joins VP of Global Regulatory Affairs, Jaishankar Kutty, Ph.D. to outline:
๐ ๐ฆ๐๐ฒ๐ฝ๐ ๐๐ผ ๐๐
๐ฒ๐ฐ๐๐๐ฒ ๐ฎ ๐ฃ๐ถ๐๐ผ๐๐ฎ๐น ๐ง๐ฟ๐ถ๐ฎ๐น:
โ Identifying key stakeholders
โ Defining study endpoints and scope
โ Budgeting and regulatory planning
๐ ๏ธ ๐ฃ๐น๐ฎ๐ป๐ป๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐๐
๐ฒ๐ฐ๐๐๐ถ๐ผ๐ป:
โ Study protocol development
โ Regulatory submissions and ethics approvals
โ Site and patient selection
๐ ๐ก๐ฎ๐๐ถ๐ด๐ฎ๐๐ถ๐ป๐ด ๐ฅ๐ฒ๐ด๐๐น๐ฎ๐๐ผ๐ฟ๐ ๐ก๐๐ฎ๐ป๐ฐ๐ฒ๐:
โ Understanding local regulations
โ Importance of local expertise
๐ ๐๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป๐:
โ Addressing patient recruitment issues
โ Site selection and vendor coordination
โ Risk management strategies
*This video is part of our educational video series on clinical trials. Clips will cover three key areas: clinical trial strategy, clinical trial execution, and regulatory expertise in clinical trials. Please โ โ โ reach out to RQM+โ โ โ if you need support with clinical trials.*